1. Appelt, S.: Early Entries and Trademarks—Barriers to Generic Entry in the German Pharmaceutical Industry? Paper presented at the DRUID-DIME Academy Winter 2009 PhD Conference, viewed at http://www2.druid.dk/conferences/viewabstract.php?id=4403&cf=33 . June 5, 2011 (2009)
2. Berndt, E.R., Kyle, M.K., Ling, D.C.: The long shadow of patent expiration: Generic entry and Rx-to-OTC switches. In: Feenstra, R.C., Shapiro, M.D. (eds.) Scanner data and price indices. University of Chicago Press, Chicago (2003)
3. Berndt, E.R., Aitken, M.L.: Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch legislation. Int. J. Econom. Business 18(2), 177–201 (2011)
4. Boland, G.L.: Federal regulation of prescription drug advertising and labeling. Boston College Law Rev. 12(2), 203–266 (1970)
5. Bond, R.S., Lean, D.S.: Sales, promotion and product differentiation in two prescription drug markets. Staff Report, Bureau of Economics. US Federal Trade Commission, Washington, DC (1977)